StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Sun Pharmaceutical Industries Limited
NSE:SUNPHARMA.NS
Sector
Location
Market Cap
USD 46.90 B
Share Price
USD 19.46
Avg Daily Volume
2,615,631
Change (1 day)
0.36%
Change (1 year)
2.82%
Change (YTD)
-11.71%
Sun Pharmaceutical Industries Limited EBIT Margin for the year ending March 31, 2025: 23.79%
Sun Pharmaceutical Industries Limited EBIT Margin is 23.79% for the year ending March 31, 2025, a 0.75% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
-
Sun Pharmaceutical Industries Limited EBIT Margin for the year ending March 31, 2024 was 23.62%, a 6.97% change year over year.
-
Sun Pharmaceutical Industries Limited EBIT Margin for the year ending March 31, 2023 was 22.08%, a 86.22% change year over year.
-
Sun Pharmaceutical Industries Limited EBIT Margin for the year ending March 31, 2022 was 11.86%, a 34.62% change year over year.
-
Sun Pharmaceutical Industries Limited EBIT Margin for the year ending March 31, 2021 was 8.81%, a -45.88% change year over year.
Competitors
Eli Lilly and Company
USD 793.01
LLY
+2.36
0.30%
Johnson & Johnson
USD 156.90
JNJ
-0.79
-0.50%
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
Bristol-Myers Squibb Company
USD 46.86
BMY
-1.66
-3.42%
McKesson Corporation
USD 709.59
MCK
-4.95
-0.69%
GSK plc
USD 18.99
GSK.L
-0.75
-3.81%
Elevance Health Inc.
USD 340.67
ELV
-5.19
-1.50%
Chugai Pharmaceutical Co., Ltd.
USD 46.36
4519.T
-0.52
-1.11%
Regeneron Pharmaceuticals, Inc.
USD 567.74
REGN
+7.98
1.43%
Cencora, Inc.
USD 295.21
COR
-2.11
-0.71%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.93
600276.SS
-0.09
-1.14%
Lonza Group AG
USD 707.88
LONN.SW
-5.04
-0.71%
Takeda Pharmaceutical Company Limited
USD 29.69
4502.T
+0.05
0.17%
Key Data
| Date | EBIT Margin | EBITDA Margin | Net Income Margin | EBT Margin |
|---|
Competitors
Eli Lilly and Company
USD 793.01
LLY
+2.36
0.30%
Johnson & Johnson
USD 156.90
JNJ
-0.79
-0.50%
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
Bristol-Myers Squibb Company
USD 46.86
BMY
-1.66
-3.42%
McKesson Corporation
USD 709.59
MCK
-4.95
-0.69%
GSK plc
USD 18.99
GSK.L
-0.75
-3.81%
Elevance Health Inc.
USD 340.67
ELV
-5.19
-1.50%
Chugai Pharmaceutical Co., Ltd.
USD 46.36
4519.T
-0.52
-1.11%
Regeneron Pharmaceuticals, Inc.
USD 567.74
REGN
+7.98
1.43%
Cencora, Inc.
USD 295.21
COR
-2.11
-0.71%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.93
600276.SS
-0.09
-1.14%
Lonza Group AG
USD 707.88
LONN.SW
-5.04
-0.71%
Takeda Pharmaceutical Company Limited
USD 29.69
4502.T
+0.05
0.17%